SLC35A2 and colonic neoplasm: EGCG intake (20 mg/kg) for 6 weeks has been reported to prevent colon cancer while upregulating Nrf2 and UDP-glucuronosyltransferases (UGT) genes, the phase II drug-metabolizing enzymes, in male BalB/cA nude mice [128].